Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

NCT00939783 ·Status: TERMINATED ·Phase: PHASE3

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

NCT00954590 ·Status: TERMINATED ·Phase: PHASE3

A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

NCT00322153 ·Status: COMPLETED ·Phase: PHASE3

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

NCT00988598 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

NCT02553928 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

NCT00257673 ·Status: COMPLETED ·Phase: PHASE2

Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease

NCT00377715 ·Status: COMPLETED ·Phase: PHASE2

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

NCT01066546 ·Status: TERMINATED ·Phase: PHASE3

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

NCT00827034 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

NCT00990613 ·Status: COMPLETED ·Phase: PHASE1

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

NCT02162251 ·Status: COMPLETED

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

NCT00675623 ·Status: COMPLETED ·Phase: PHASE3

An Extension of the CONCERT Protocol (DIM18)

NCT01152216 ·Status: TERMINATED ·Phase: PHASE3

SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study

NCT02580305 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

NCT00857649 ·Status: TERMINATED ·Phase: PHASE3

The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

NCT00293176 ·Status: COMPLETED ·Phase: PHASE4

Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

NCT00704782 ·Status: TERMINATED ·Phase: PHASE2

Multicenter Evaluation of Memory Remediation After TBI With Donepezil

NCT02255799 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

NCT00857233 ·Status: TERMINATED ·Phase: PHASE3

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

NCT00551161 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)

NCT01600859 ·Status: COMPLETED ·Phase: PHASE1

Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

NCT00545974 ·Status: COMPLETED ·Phase: PHASE4

Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease

NCT00305903 ·Status: COMPLETED ·Phase: PHASE4

Brain Imaging and Mental Disorders of Aging Intervention

NCT00267163 ·Status: COMPLETED ·Phase: PHASE4

Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia

NCT00294554 ·Status: COMPLETED ·Phase: NA